Replies to post #183265 on Biotech Values

[DewDiligence]

RPRX laugher re Androxal:

http://finance.yahoo.com/news/repros-updates-androxal-r-global-211500532.html

Overall, the Company believes there are no Refuse-To-File issues for its NDA [emphasis added].

This is something to tout?

[DewDiligence]

RPRX submits Androxal NDA:

http://finance.yahoo.com/news/repros-submits-drug-application-fda-141500585.html

Wouldn’t bet on a first-cycle approval for this.